Bladder Cancer drug shortage resolved with Health Canada approval
TORONTO, Feb. 24, 2021 /CNW/ – Verity Pharmaceuticals Inc. is pleased to announce that it has received a notice of compliance with conditions (NOC/c) from Health Canada for the VERITY-BCG™ (Bacillus Calmette-GuĂ©rin [BCG]: Strain Russian BCG-I). This approval is welcome news for patients and health care providers who have endured a Canadian and global shortage of … Continue reading Bladder Cancer drug shortage resolved with Health Canada approval
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed